Gut microbiota modulation as an alternative in the management of non-alcoholic fatty liver disease and obesity
- Autores: María Juárez Fernández
- Directores de la Tesis: Sonia Sánchez Campos (dir. tes.), Javier González Gallego (dir. tes.), María Victoria García-Mediavilla (tut. tes.)
- Lectura: En la Universidad de León ( España ) en 2023
- Idioma: inglés
- Número de páginas: 155
- Títulos paralelos:
- Modulación de la microbiota intestinal como alternativa terapéutica en el manejo de la enfermedad de hígado graso no alcohólico y la obesidad
- Tribunal Calificador de la Tesis: Gracia Merino Peláez (presid.), Luis Vaquero (secret.), Alberto Caminero Fernández (voc.)
- Programa de doctorado: Programa de Doctorado en Biomedicina y Ciencias de la Salud por la Universidad de León
- Materias:
- Enlaces
- Tesis en acceso abierto en: BULERIA
- Resumen
Nowadays, obesity and NAFLD are two of the most important public health concerns worldwide. The lack of an effective treatment to face them, along with the current sedentary lifestyle and the intake of high-fat and high-sugar diets have led to an increasing trend in the prevalence of both diseases, with shocking future estimations. In the last years, gut microbiota has been identified as a key contributor factor to the development of these diseases, so it has become a research field not only in the characterization of the pathogenic mechanisms, but also in the hunt for new therapeutic alternatives. In this sense, the modulation of gut microbiota through different strategies such as fecal microbiota transplantation or the administration of probiotics, prebiotics, and synbiotics are being considered as possible treatments to face both obesity and NAFLD. In the present PhD Thesis, the general aim is to identify the role of the gut microbiota in the pathogenesis of these two diseases, as well as to explore the therapeutic potential of gut microbiota modulation.
